PMV Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PMV Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • PMV Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.9M, a 11.5% decline year-over-year.
  • PMV Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$79.2M, a 3.9% increase year-over-year.
  • PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$80.1M, a 4.01% decline from 2022.
  • PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$77M, a 32.2% decline from 2021.
  • PMV Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$58.3M, a 66.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$80.1M -$3.09M -4.01% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$77M -$18.7M -32.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$58.3M -$23.4M -66.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$34.9M -$8.31M -31.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$26.6M -$7.75M -41% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$18.9M Jan 1, 2018 Dec 31, 2018 10-K 2021-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.